Browsing by Author "d8c3086d-6a25-4fbd-a358-2d56b598dae7"

Now showing items 1-2 of 2

    • Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy ... 
      Santolaya de Pablo, María Elena; O'Ryan Gallardo, Miguel; Valenzuela Bravo, María Teresa; Prado Jiménez, Valeria; Vergara, Rodrigo C.; Muñoz, Alma; Toneatto, Daniela; Graña, Gabriela; Wang, Huajun; Clemens, Ralf; Dull, Peter M. (Elsevier, 2012-02-18)
      Background Effective glycoconjugate vaccines against Neisseria meningitidis serogroups A, C, W-135, and Y have been developed, but serogroup B remains a major cause of severe invasive disease in infants and adolescents ...
    • Persistence of antibodies in adolescents 18-24 months after immunization with one, two, or three doses of ... 
      Santolaya de Pablo, María Elena; O'Ryan Gallardo, Miguel; Valenzuela, María Teresa; Prado Jiménez, Valeria; Vergara, Rodrigo F.; Muñoz, Alma; Toneatto, Daniela; Graña, Gabriela; Wang, Huajun; Dull, Peter M. (Taylor & Francis, 2013)
      We previously demonstrated the immunogenicity and tolerability of the serogroup B meningococcal vaccine, 4CMenB (Bexsero®), in 11-17 y-olds randomized to receive 1, 2, or 3 doses at 1, 2, or 6 mo intervals. participants ...